Shin et al. recently reported44 that NF-κB activity alone may not be sufficient to induce PDL1 expression; instead, PDL1 expression might increase following treatment with IFN-γ in HNSCC. The gene discussed is NFKB1; the disease is head and neck squamous cell carcinoma.